Stay updated on Illumina Press Releases
Sign up to get notified when there's something new on the Illumina Press Releases page.
Latest updates to the Illumina Press Releases page
- Check2 days agoChange DetectedIllumina has recently achieved significant milestones, including a favorable ruling from the European Court of Justice and FDA approval for a cancer genomic profiling assay, while previous updates on strategy and genomic sequencing efforts have been removed.SummaryDifference100%
- Check9 days agoChange DetectedIllumina has made significant advancements, including FDA approval for a cancer biomarker test and a collaboration with the Broad Institute on new gene sequencing kits, while also announcing a strategic simplification of DNA sequencing and analysis to drive growth.SummaryDifference100%
- Check16 days agoChange DetectedOn August 20, 2024, the value increased to 132.51, reflecting a positive change, while the previous value on August 13, 2024, was lower at 119.72.SummaryDifference63%
- Check23 days agoChange DetectedNew podcast episode featuring Bret Barnes discussing epigenetics and its implications for cancer and aging, along with Illumina's strategy announcement to enhance value creation.SummaryDifference100%
- Check31 days agoChange DetectedIllumina has reported its financial results for Q2 2024 and launched a new oncology menu for the NovaSeq X Series, while notable previous updates regarding the divestiture of GRAIL and advancements in genome sequencing technology have been removed.SummaryDifference100%
- Check38 days agoChange DetectedThe website now highlights a STEM boot camp for students and Illumina employees, along with a paid summer experience for San Diego youth, while removing information about the iHope China program's expansion.SummaryDifference59%
Stay in the know with updates to Illumina Press Releases
Enter your email address, and we'll notify you when there's something new on the Illumina Press Releases page.